Compare BioNano Genomics Inc (BNGO) vs iShares Self-Driving EV and Tech (IDRV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs iShares Self-Driving EV and Tech — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.20M), while iShares Self-Driving EV and Tech trades at $36.65. The key difference: iShares Self-Driving EV and Tech is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | IDRV | |
|---|---|---|
Market Cap | $13.20M | — |
Sector | Health | Sector/Thematic |
52-Week High | $4.92 | $45.48 |
52-Week Low | $1.09 | $32.13 |
Enterprise Value | $15.81M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.
BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.
IDRV trades at $36.35, down 1.38% with a bearish technical signal from moving averages. The ETF shows neutral oscillators but lacks disclosed fundamental ratios. Recent news highlights strong global EV sales growth, particularly in China and Europe, driven by high fuel prices and policy support, though U.S. adoption lags.
Outlook is mixed: positive EV industry momentum contrasts with technical weakness and U.S. market challenges. Key risks include regulatory shifts, competition, and reliance on macroeconomic factors. Investors should weigh sector growth against ETF-specific performance and market sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About iShares Self-Driving EV and Tech
IDRV invests in global companies at the forefront of self-driving and electric vehicle innovation. It provides exposure to the full EV value chain, including battery technology and autonomous systems, with top holdings like Albemarle, Rivian, and Tesla.
Read more on IDRV →
